Also known as Zynteglo, this gene therapy won European approvals but bluebird has since withdrawn from the European market following failed ...
https://www.google.com/url?rct=j&sa=t&url=https://www.thepharmaletter.com/article/bluebird-s-beti-cel-good-value-at-2-1-million-icer-says&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw3qCWvB6pbrEYrDWo5SEDDi
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.